2025 Annual Meeting | C18 - Spanish: Neuroinmunología (Neuroimmunology)

Date Saturday 04/05/25

Time 12:00 PM - 02:00 PM PDT Add To Calendar

Location San Diego Convention Center | 24C

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Daniel Ontaneda, MD, PhD, FAAN

Topic(s) Multiple Sclerosis

Learning Objectives Participants should become familiar with how to identify the new components of the 2024 MS diagnostic criteria, blood biomarkers for MS diagnosis, and novel imaging diagnostic biomarkers in MS.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Program Tracks Spanish Language

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
12:00 PM - 12:40 PM PDT	Speaker	Nuevos criterios diagnosticos de la esclerosis multiple: revisiones 2024 Daniel Ontaneda, MD, PhD, FAAN
12:40 PM - 01:20 PM PDT	Speaker	Biomarcadores diagnosticos en liquido cefaloraquideo y sangre para esclerosis multiple Enrique Alvarez, MD, PhD
01:20 PM - 02:00 PM PDT	Speaker	Signo de la vena central y anillo paramagnetico como biomarcadores para el diagnostico de esclerosis multiple Maria Gaitan, MD

Faculty Disclosures
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Enrique Alvarez, MD, PhD	Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Maria Gaitan, MD	Dr. Gaitan has nothing to disclose.

��ɫ��

��ɫ��